EP3909941
INTERMEDIATES OF 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)-PYRIDIN-3-YL)METHOXY)BENZALDEHYDE
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
11.5.2017EP published:
15.4.2026EP application number:
21168857.7
EPO information:
European Patent Register
Max expiry date:
10.5.2037Expiry date:
14.8.2026
Title in English:
INTERMEDIATES OF 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)-PYRIDIN-3-YL)METHOXY)BENZALDEHYDELanguage of the patent:
English
Timeline
Today
11.5.2017EP application
15.4.2026EP Publication
14.8.2026Expires
Owner
Name:
Global Blood Therapeutics, Inc.Address:
181 Oyster Point Boulevard, South San Francisco, CA 94080, US
Inventor
Name:
LI, ZheAddress:
South San Francisco, 94080, US
Name:
GUZ, NathanAddress:
South San Francisco, 94080, US
Name:
SHAO, YiyangAddress:
South San Francisco, 94080, US
Name:
COCUZ, JulieanaAddress:
South San Francisco, 94080, US
Name:
FRIESER, MarkusAddress:
South San Francisco, 94080, US
Name:
YIANNIKOUROS, George, PetrosAddress:
South San Francisco, 94080, US
Name:
LIAO, LiangAddress:
South San Francisco, 94080, US
Priority
Number:
201662335583 PDate:
12.5.2016Country:
US
Classification
Categories:
C07C 47/56